148
Participants
Start Date
June 30, 2012
Primary Completion Date
July 31, 2014
Study Completion Date
January 31, 2015
.9 normal saline placebo
Administration of .9 normal saline placebo as a bolus and as maintenance throughout the length of the surgical procedure.
Group L (lidocaine)
Group L will receive a 1.5 mg/kg bolus of intravenous lidocaine followed by a 2mg/kg/hr infusion that will be started at the time of surgical induction and will be discontinued one hour after the end of the surgical procedure.
Prentice Womens' Hospital, Chicago
Northwestern University
OTHER